A Comparison of 4 Multiple Sclerosis Rx from Patient's Feedback

07/26/2023, 6:20 PM — 6:30 PM UTC
32-124

Abstract:

Identified 4 Multiple Sclerosis drugs: Gilenya, Tysabri, Copaxone, and Tecfidera as the basis for conducting a manual textual analysis from feedback provided by patients at WebMD website. The objective was two fold: (1) complete a textual analysis, evaluating, on the dimensions of Ease of Use, Effectiveness, and Satisfaction. After categorizing different feedback into various groups, these data were visualized and analyzed using Julia

Description:

Identified 4 Multiple Sclerosis drugs: Gilenya, Tysabri, Copaxone, and Tecfidera as the basis for conducting a manual textual analysis from feedback provided by patients at WebMD website. The objective was two fold: (1) complete a textual analysis, evaluating, on the dimensions of Ease of Use, Effectiveness, and Satisfaction. After categorizing different feedback into various groups, these data were visualized and analyzed using Julia. Each brand had at least a minimum of 100 unique patients providing feedback - Tysabri had 222, Gilenya had 102, Tecfidera had 162 and Copaxone had 198. Analysis will include basic means comparisons using ANOVA based analysis in Julia

Platinum sponsors

JuliaHub

Gold sponsors

ASML

Silver sponsors

Pumas AIQuEra Computing Inc.Relational AIJeffrey Sarnoff

Bronze sponsors

Jolin.ioBeacon BiosignalsMIT CSAILBoeing

Academic partners

NAWA

Local partners

Postmates

Fiscal Sponsor

NumFOCUS